H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 9.9% of adults in Murfreesboro have diagnosed diabetes — 2.1 points below the U.S. 12% figure. Census population 152,769. Tennessee Medicare wound biologics: Palmetto GBA (JJ). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Murfreesboro clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Murfreesboro storefront.
Orthobiologic Treatments for Your Practice in Murfreesboro, TN for clinics & physicians. Compliance support & pricing — contact Hawk Medical.
Murfreesboro is a city under 250k (152,769 Census). CDC PLACES (2023, crude) estimates 9.9% of adults in Murfreesboro have diagnosed diabetes — 2.1 points below the U.S. 12% figure. Adult arthritis here is 24.4% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Orthobiologic Treatments for Your Practice notes (how the product actually works)CDC PLACES (2023, crude) estimates 9.9% of adults in Murfreesboro have diagnosed diabetes — 2.1 points below the U.S. 12% figure. Adult obesity in Murfreesboro is 37.3% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 24.4% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JJ / Palmetto GBA, sibling states AL, GA. Tennessee Department of Health is the public-health home. We will not mash those grains into a fake “demand score.”
If you already buy orthobiologic treatments elsewhere, use this page as a check: homologous-use language, current Palmetto GBA article IDs, and PLACES 9.9% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 9.9% of adults — 2.1 points below the U.S. 12% figure. Obesity is 37.3%; arthritis is 24.4%. That is place-level BRFSS modeling, not a clinic census and not a Murfreesboro trial.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. Palmetto GBA LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
No. Hawk Medical LLC is a national distributor founded in 2014. We ship HCT/P 361-compliant tissue, PRP systems, and wound-care biologics to physician practices nationwide, including Tennessee. There is no Murfreesboro storefront or local street address on this page because we are a service-area distributor, not a walk-in clinic.
If you operate in Tennessee and another MAC state, say it on the first call. JJ will not port 1:1. We would rather split utilization than watch a sister clinic copy Murfreesboro tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Murfreesboro, TN.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Murfreesboro is JJ geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Murfreesboro — 2.1 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Tennessee Part B wound biologics follow this contractor (siblings: AL, GA). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Murfreesboro. Useful for joint-program math; still needs a diagnosis and privileging.
No Murfreesboro storefront. Joe Bradley is an active practice owner. orthobiologic treatments stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.